TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FARISEDIN

This trademark appears in the official INPI history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

Registro ExtintoType: WordOffice: Brazil

Quick snapshot

FARISEDIN

ST13

BR500000003464814

Class

5

Filing

003464814

Registration

003464814

Progress at the INPI

  1. Filing06/14/61
  2. Publication
  3. Examination
  4. Allowance
  5. Grant12/30/66
  6. Terminated07/15/97

The registration was granted on 12/30/1966 and later terminated. The mark is no longer protected.

Check whether this name is available

Latest action published by the INPI: 07/15/1997. We update with every new RPI gazette, published weekly.

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

INPI status

Registro Extinto

Case type

Application and registration

Recorded events

2

Latest update

07/15/1997

Trademark type

Word

Nice classes

5

Filing date

06/14/1961

Registration date

12/30/1966

Expiration date

12/30/1996

Complete case details

Structured fields from the responsible authority and the official record.

Nature

De Produto

Responsible office

Brazil

Owner type

PESSOA JURÍDICA

Owner location

SP, BR

Holders and representatives

Holders

LABORATORIO AMERICANO DE FARMACOTERAPIA S/A

Representatives

No representative data.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicamentos antibióticos e quimioterápicos

Publications

History of INPI decisions and trademark events.

2 publications found

700

Registro EXTINTO, com base na norma legal indicada.

INCISO I DO ART 142 DA LPI *INT. MOMSEN, LEONARDOS & CIA

RPI 1389

07/15/1997

990

CONCEDIDA A PRORROGACAO DO REGISTRO. O Certificado de prorrogacao de Registro estara a disposicao do Titular na Recepcao da Diretoria de Marcas, apos 60 (sessenta) dias a contar desta data. Podera, a pedido, ser remetido a qualquer Delegacia e/ou Representacao do INPI/MICT.

RPI 816

06/10/1986

LABORATORIO AMERICANO DE FARMACOTERAPIA S/A also protects technology and design at the INPI

1 patent application under the same owner.

Related trademarks

Other trademarks by LABORATORIO AMERICANO DE FARMACOTERAPIA S/A

Continuous trademark protection

Get notified about every new filing that threatens FARISEDIN or your mark.

Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.